Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants.

[1]  N. Laroia,et al.  Chronic Auditory Toxicity in Late Preterm and Term Infants With Significant Hyperbilirubinemia , 2017, Pediatrics.

[2]  J. Pardo,et al.  Hearing outcome of infants with congenital cytomegalovirus and hearing impairment , 2016, Archives of Disease in Childhood.

[3]  A. Herring,et al.  Diuretic Exposure in Premature Infants from 1997 to 2011 , 2014, American Journal of Perinatology.

[4]  J. Slaughter,et al.  Variation in the Use of Diuretic Therapy for Infants With Bronchopulmonary Dysplasia , 2013, Pediatrics.

[5]  P. Smith,et al.  Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. , 2012, Early human development.

[6]  M. Walsh,et al.  Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. , 2011, American journal of respiratory and critical care medicine.

[7]  A. Goedegebure,et al.  An initial overestimation of sensorineural hearing loss in NICU infants after failure on neonatal hearing screening. , 2011, International journal of pediatric otorhinolaryngology.

[8]  A. Goedegebure,et al.  Risk factors for sensorineural hearing loss in NICU infants compared to normal hearing NICU controls. , 2010, International journal of pediatric otorhinolaryngology.

[9]  A. Spitzer,et al.  The Pediatrix BabySteps Data Warehouse and the Pediatrix QualitySteps improvement project system--tools for "meaningful use" in continuous quality improvement. , 2010, Clinics in perinatology.

[10]  Elizabeth A Stuart,et al.  Matching methods for causal inference: A review and a look forward. , 2010, Statistical science : a review journal of the Institute of Mathematical Statistics.

[11]  G. Imbens,et al.  Matching on the Estimated Propensity Score , 2009 .

[12]  G. Sakoulas,et al.  Vancomycin Ototoxicity: a Reevaluation in an Era of Increasing Doses , 2008, Antimicrobial Agents and Chemotherapy.

[13]  M. Walsh,et al.  Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia , 2005, Pediatrics.

[14]  M. Majd,et al.  Use of furosemide and hearing loss in neonatal intensive care survivors. , 2004, American journal of perinatology.

[15]  L. Brion,et al.  Diuretics and Chronic Lung Disease of Prematurity , 2001, Journal of Perinatology.

[16]  T. O'Shea,et al.  Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants , 1999 .

[17]  L. Lilien,et al.  A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. , 1997, Pediatrics.

[18]  J. Watchko,et al.  NEONATAL SENSORINEURAL HEARING LOSS ASSOCIATED WITH FUROSEMIDE: A CASE‐CONTROL STUDY , 1991, Developmental medicine and child neurology.

[19]  A. Salamy,et al.  Neonatal status and hearing loss in high-risk infants. , 1989, The Journal of pediatrics.

[20]  T. Morizono,et al.  Effect of furosemide upon endolymph potassium concentration , 1982, Hearing Research.

[21]  P. Bernard.  Freedom from ototoxicity in aminoglycoside treated neonates: A mistaken notion , 1981, The Laryngoscope.

[22]  B. Rumack,et al.  Pharmacology of furosemide in the premature newborn infant. , 1980, The Journal of pediatrics.

[23]  J. Jones,et al.  Furosemide-induced ototoxicity. , 1979, Annals of internal medicine.

[24]  D. Sitar,et al.  Pharmacokinetic disposition and protein binding of furosemide in newborn infants. , 1978, The Journal of pediatrics.

[25]  A. Stark,et al.  Bronchopulmonary dysplasia: possible relationship to pulmonary edema. , 1978, The Journal of pediatrics.

[26]  R. Brummett,et al.  Cochlear damage resulting from kanamycin and furosemide. , 1975, Acta oto-laryngologica.

[27]  C. Brown,et al.  High Dose Frusemide in Acute Reversible Intrinsic Renal Failure , 1974, Scottish medical journal.

[28]  M. Wigand,et al.  Ototoxic side-effects of high doses of frusemide in patients with uraemia , 1971, Postgraduate medical journal.

[29]  R. Riggio,et al.  Ototoxicity induced by furosemide. , 1970, The New England journal of medicine.

[30]  W. Hop,et al.  Newborn hearing screening: tobramycin and vancomycin are not risk factors for hearing loss. , 2003, The Journal of pediatrics.

[31]  C R Bauer,et al.  Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. , 2001, Pediatrics.

[32]  J. Tyson,et al.  Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. , 1998, American journal of obstetrics and gynecology.

[33]  T. Buclin,et al.  Risk factors of sensorineural hearing loss in preterm infants. , 1997, Biology of the neonate.

[34]  D. Anagnostakis,et al.  Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate 1997;71:1-10. , 1997, Biology of the neonate.

[35]  K. Koga,et al.  Delayed post-neonatal intensive care unit hearing disturbance. , 1996, International journal of pediatric otorhinolaryngology.